Form 4: OptimizeRx Director James Paul Lang Acquires Shares in Open Market

Director James Paul Lang purchased 321,408 shares of OptimizeRx Corp (OPRX) at a weighted average price of $7.6033 on March 14, 2025.

Summary

• On March 14, 2025, James Paul Lang, a director of OptimizeRx Corp (OPRX), acquired 321,408 shares of common stock.
• The shares were purchased at a weighted average price of $7.6033.
• Following the transaction, Lang directly owns 389,452 shares of OptimizeRx Corp.
• The filing explicitly states that it should not be construed as an admission of beneficial ownership or that the statement is legally required.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of a director's share purchase. The purchase itself could be seen as a slightly positive signal, but without further context, it's difficult to gauge the overall impact.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor their actions and assess their confidence in the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder confidence, as insider buying is often seen as a sign of management's belief in the company's future prospects.

Key Dates

Keywords

OptimizeRx Corp, OPRX, James Paul Lang, Director, Share Acquisition, Form 4, SEC Filing, Beneficial Ownership